We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Neuroimaging Reveals Brain Reorganizes To Adjust for Loss of Vision

By LabMedica International staff writers
Posted on 23 Dec 2008
A new study has revealed that when individuals with macular degeneration focus on using another part of their retina to compensate for their loss of central vision, their brain seems to compensate by reorganizing its neural connections. More...


Age-related macular degeneration is the leading cause of blindness in the elderly. In the study, a functional magnetic resonance imaging (fMRI) scan of the brain revealed increased activity when patients use their preferred retinal locations. "Our results show that the patient's behavior may be critical to get the brain to reorganize in response to disease,” said Dr. Eric Schumacher, assistant professor in Georgia Institute of Technology's (Georgia Tech; Atlanta, USA) School of Psychology. "It's not enough to lose input to a brain region for that region to reorganize; the change in the patient's behavior also matters.”

In this case, that change of behavior comes when patients with macular degeneration, a disease in which damage to the retina causes patients to lose their vision in the center of their visual field, make up for this loss by focusing with other parts of their visual field.

Previous research in this area showed contradictory results. Some studies suggested that the primary visual cortex, the first part of the cortex to receive visual information from the eyes, reorganizes itself, but other studies suggested that this did not occur. Dr. Schumacher and his graduate student, Keith Main, worked with researchers from the Georgia Tech/Emory Wallace H. Coulter department of biomedical engineering and the Emory Eye Center. They assessed whether the patients' use of other areas outside their central visual field, known as preferred retinal locations, to compensate for their damaged retinas drives, or is related to, this reorganization in the visual cortex.

The researchers presented 13 volunteers with a series of tests designed to visually stimulate their peripheral regions and measure brain activity while undergoing fMRI scanning. They found that when patients visually stimulated the preferred retinal locations, they increased brain activity in the same parts of the visual cortex that are typically activated when healthy patients focused on objects in their central visual field. They concluded that the brain had reorganized itself.

The parts of the visual cortex that process information from the central visual field in patients with normal vision were reprogrammed to process information from other parts of the eye, regions that macular degeneration patients use instead of their central visual areas. While there is evidence with other tasks that suggests that the brain can reorganize itself, this is the first study to directly demonstrate that this reorganization in patients with retinal disease is related to patient behavior.

The researchers are currently studying how long this reorganization takes and whether it can be enhanced through low-vision training. The study appears in the December 2008 issue of the journal Restorative Neurology and Neuroscience.

Related Links:
Georgia Institute of Technology


Gold Member
Automatic Hematology Analyzer
CF9600
Online QC Software
Acusera 24•7
Electrolyte Analyzer
BKE-B
New
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Graphical Abstract (Morgane Fournier et al., Cell (2026). DOI: 10.1016/j.cell.2026.04.013)

Study Reveals Immune Mechanism Driving Severe COVID-19 Progression

Severe COVID-19 has highlighted gaps in understanding of early antiviral responses, particularly why some patients deteriorate despite timely care. Type I interferons are central to host defense, yet their... Read more

Pathology

view channel
Image: Agilent’s PD-L1 IHC 22C3 pharmDx has received EU certification as a companion diagnostic to identify PD-L1–positive ovarian, fallopian tube, or primary peritoneal carcinoma patients eligible for KEYTRUDA (Photo courtesy of Agilent)

PD-L1 Assay Guides Pembrolizumab Eligibility in Ovarian, Fallopian Tube, and Peritoneal Cancers

Agilent Technologies’ PD-L1 IHC 22C3 pharmDx (Code SK006) has received European Union certification as a companion diagnostic to aid in identifying patients with epithelial ovarian, fallopian tube, or... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.